![]() |
市場調查報告書
商品編碼
1482347
肉毒桿菌毒素市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍:按產品、應用、最終用戶和地理位置Botulinum Toxin Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Application, End User, and Geography |
依據「2031 年肉毒桿菌市場預測 - 全球分析 - 按產品、應用和最終用戶」的最新研究,2023 年市場價值為 73.8 億美元,預計到 2030 年將達到 190.3 億美元。 2031 年複合年成長率為12.6%。
肉毒桿菌毒素是由肉毒桿菌產生的神經毒素。將毒素注射到肌肉後,它會阻斷向肌肉發出的神經訊號,從而阻止其收縮並減少不必要的臉部線條或特徵。 Botox 和 Dysport 等肉毒桿菌注射可透過放鬆引起皺紋的肌肉來改善外觀。這些注射還可以治療偏頭痛、多汗症、膀胱過動症和眼部問題。
使用注射肉毒桿菌毒素、羥基磷灰石鈣和透明質酸等進行臉部年輕化的非侵入性手術。這些手術的副作用最小,有助於減少橘皮組織、皺紋、臉部細紋和多餘的脂肪。自然年輕化的概念是基於全面、多層、3D的方法,根據具體需求,在體積擴大、皮膚鬆弛、重塑、體積重新定位、皮膚緊緻和表面更新等程序中結合多種技術和活性成分的患者。最常用的非手術臉部手術是化學換膚、雷射換膚、軟組織填充劑和肉毒桿菌。與風險較大的外科手術不同,微創手術透過更快的恢復、更少的疤痕、有限的壓力和更好的患者滿意度使患者受益。此外,消費者對健康、美麗和美好老化的看法不斷變化,可以讓全世界更好地理解和接受美學。根據國際美容整形外科學會(ISAPS)的數據,2021年非手術手術數量較2020年增加了19.9%。市場的成長。
。
按應用分類,肉毒桿菌市場洞察
肉毒桿菌毒素市場依應用分為醫療和美容。醫療領域在 2023 年佔據最大的肉毒桿菌毒素市場佔有率,預計 2023 年至 2031 年複合年成長率最高,達 13.3%。醫學部分進一步分為慢性偏頭痛、肌肉痙攣、膀胱過度反應、多汗症等。美容細分市場進一步分為眉間紋/眉間紋、額頭紋、魚尾紋、方下巴/咬肌等。肉毒桿菌毒素是一種神經毒素,用於治療和控制各種疾病,包括慢性偏頭痛、痙攣性疾病、頸部肌張力失調和逼尿肌過度活躍。肉毒桿菌毒素的醫學應用包括慢性偏頭痛、肌肉痙攣、膀胱過度反應和多汗症。慢性偏頭痛是一種嚴重致殘的神經系統疾病,其特徵是搏動性單側或雙側頭痛。它主要被描述為一種頭痛,在三個月內每月至少困擾個人 15 天。肉毒桿菌注射也被發現可有效治療腦性麻痺,使患者的嚴重肌肉收縮得到顯著緩解。 A 型肉毒桿菌毒素治療慢性腰痛的有效性也得到了研究。
按最終用戶,基於肉毒桿菌市場的見解
從類型來看,肉毒桿菌市場分為專科和皮膚科診所、醫院和診所等。 2023年,專科和皮膚科診所細分市場佔有最大的市場佔有率。有效的服務的能力服務。這些患者通常有特定的皮膚狀況,需要專家評估和管理。皮膚科診所提供的肉毒桿菌毒素治療專為解決這些特定問題而量身定做,其定製配方旨在針對皮膚問題的根本原因。在過去的十年裡,整容手術變得更加普遍。此外,微創技術的引入增加了皮膚科手術的普及。肉毒桿菌注射、透明質酸治療、雷射除毛、非手術減脂和光子嫩膚/強烈脈衝光 (IPL) 是皮膚科診所最常見的非手術美容手術。
國際美容整形外科學會和國家健康與護理卓越研究所是在準備肉毒毒素市場報告時提到的一些主要二手來源。
註 - 將為以下提到的地區/國家提供類似的分析
According to our latest study on "Botulinum Toxin Market Forecast to 2031 - Global Analysis - by Product, Application, and End User" the market was valued at US$ 7.38 billion in 2023 and is expected to reach US$ 19.03 billion by 2030. It is estimated to register a CAGR of 12.6% from 2023 to 2031.
Botulinum toxins are neurotoxins produced by bacteria named Clostridium botulinum. After the toxin is injected into a muscle, it blocks nerve signals to the muscle, thereby blocking its contraction and reducing unwanted facial lines or features. Botulinum toxin injections such as Botox and Dysport improve the appearance by relaxing the muscles that cause wrinkles. These injections also treat migraines, hyperhidrosis, overactive bladder, and eye problems.
Noninvasive procedures of facial rejuvenation using injections of botulinum toxin, calcium hydroxylapatite, and hyaluronic acid, among others. These procedures have minimal side effects and help reduce cellulite, wrinkles, facial lines, and unwanted fat. The concept of natural rejuvenation is based on a comprehensive, multilayered, three-dimensional approach that combines multiple techniques and active ingredients in procedures such as volume enlargement, skin relaxation, reshaping, volume repositioning, skin tightening, and surface renewal, depending on specific needs of patients. The most often used non-surgical face procedures are chemical peels, laser skin resurfacing, soft tissue fillers, and Botox. Unlike surgical procedures that are associated with greater risks, minimally invasive procedures benefit patients through faster recovery, lesser scarring, limited stress, and better patient satisfaction. Moreover, changing consumer views about wellness, beauty, and good aging results in a better understanding and acceptance of aesthetics worldwide. According to the International Society of Aesthetic Plastic Surgery (ISAPS), the number of nonsurgical procedures increased by 19.9% in 2021 compared to 2020. The total number of nonsurgical procedures was 17.5 million in 2021. Thus, an upsurge in the adoption of noninvasive aesthetic procedures is driving the growth of the botulinum toxin market.
.
By Application, Botulinum Toxin Market-Based Insights
The botulinum toxin market, by application, is bifurcated into medical and aesthetic. The medical segment held the largest botulinum toxin market share in 2023 and is anticipated to register the highest CAGR of 13.3% during 2023-2031. The medical segment is further categorized into chronic migraine, muscle spasm, over reactive bladder, hyperhidrosis, and others. The market for the aesthetic segment is further divided into frown lines/ glabellar, forehead lines, crow's feet, square jaw/ masseter, and others. Botulinum toxin is a neurotoxin used to treat and manage various medical conditions, including chronic migraine, spastic disorders, cervical dystonia, and detrusor hyperactivity. Medical applications of botulinum toxin include chronic migraine, muscle spasms, overreactive bladder, and hyperhidrosis. Chronic migraine is a severely disabling neurological disorder characterized by pulsating unilateral or bilateral headaches. It is primarily described as a headache that troubles individuals for at least 15 days per month for three months. Botulinum toxin injections have also been found to be effective in treating cerebral palsy, providing patients with major relief from severe muscle contraction. Botulinum toxin A has also been studied for its effectiveness in treating chronic lower back pain.
By End User, Botulinum Toxin Market-Based Insights
In terms of type, the botulinum toxin market is categorized into specialty and dermatology clinics, hospitals and clinics, and others. The specialty and dermatology clinics segment held the largest market share in 2023. The botulinum toxin market growth in this segment is attributed to the patients' inclination toward dermatology clinics for their specialized dermatology treatment needs, and the ability of these clinics to provide rapid and effective services. These patients usually have specific skin conditions that require expert evaluation and management. Botulinum toxin treatments offered in dermatology clinics are tailored to address these specific concerns, with customized formulations designed to target the underlying causes of skin problems. Cosmetic procedures have become more widespread in the last 10 years. Moreover, the introduction of minimally invasive techniques has added to the popularity of dermatological procedures. Botulinum toxin injections, hyaluronic acid treatments, laser hair removal, nonsurgical fat reduction, and photorejuvenation/intense pulse light (IPL) have been the most common nonsurgical cosmetic procedures that are performed in dermatology clinics.
International Society of Aesthetic Plastic Surgery, and National Institute for Health and Care Excellence are a few of the major secondary sources referred to while preparing the report on the botulinum toxin market.
Note - Similar analysis would be provided for below mentioned regions/countries
Note - Similar information would be provided for below list of companies